Dr Shirish Ingawale
Director of Device & Combination Product Development, Takeda

About

Shirish Ingawale, MS, PhD, is Director of Device & Combination Product Development at Takeda.

He brings more than 20 years of experience in medical devices, drug delivery technologies and combination products across academia and the medical device, biotechnology and pharmaceutical industries. Dr Ingawale leads strategic innovation and cross-functional development to advance patient-centred device and combination product solutions.

Contributions

WEARABLES

THE PERCEPTION PROBLEM WITH SC VOLUME LIMITS AND ITS DRUG DEVELOPMENT COST

Dr Haydon DuMond, Dr Mehul Desai, along with Dr Shirish Ingawale, examine survey evidence and regulatory precedent showing that the widely cited 2–3 mL limit on subcutaneous delivery reflects device history and information habits rather than tissue biology, and consider the consequences for formulation strategy, device selection and the growing pipeline of large-volume subcutaneous therapies.